Emerging alternatives that may change duration considerations The GLP-1 agonist space is evolving rapidly
What are the roles of calorie restriction and diet quality in promoting healthy longevity
GLP-1 is contraindicated in patients including but not limited to: those with a personal or family history of medullary thyroid cancer, patients with multiple endocrine neoplasia type 2, patients with a hypersensitivity reaction to GLP-1 or any of the product components, as well as patients with pancreatitis, kidney disease, diabetic retinopathy or gallbladder disease
Here's what we'll cover Here's what we'll cover Here's what we'll cover Key takeaways Tirzepatide is the active ingredient in Mounjaro and Zepbound, two injectable medications that are prescribed for weight loss, type 2 diabetes, and obstructive sleep apnea
It recommended semaglutide be considered for weight loss in people with established cardiovascular disease, like a history of heart attacks, to reduce future risk